Document is current
Any future updates will be listed below
-
Authors
Kranidioti, Hariklia
Zisimopoulos, Konstantinos
Oikonomou, Theodora
Voulgaris, Theodoros
Siakavellas, Spyros
Agorastou, Polixeni
Deutsch, Melanie
Triantos, Christos
Goulis, Ioannis
Papatheodoridis, George
Manolakopoulos, Spilios
-
Funding
Funding for this research was provided by:
This study was supported by an unrestricted grant from Gilead Sciences
- License Information
-
More Information
Article History
Received: 18 November 2023
Accepted: 11 March 2024
First Online: 12 April 2024
Declarations
:
: The study was approved by the Ethics committee of the participating centers (General Hospital of Athens “Hippocration”, General Hospital of Thessaloniki “Hippocration”, University of Patras, General Hospital of Athens “Laiko”) and was conducted according to the principles of the Declaration of Helsinki. The requirement for informed consent was waived by the Ethics Committee of the centers because we collected retrospectively, in the majority of the patients, ordinary clinical data.
: Not applicable.
: P.A: lecturer for Gilead and AbbVie, M.D: lecturer for Gilead, C.T.: lectures/research/conference coverage by MSD, Roche, Abbvie, Bristol-Myers Squibb, Bayer, Janssen and Gilead Sciences, I.G. has received grants from Gilead, G.P.: advisor/lecturer for Abbvie, Amgen, Dicerna, Gilead, GlaxoSmithKline, Ipsen, Janssen, Merck Sharp & Dohme, Novo Nordisk, Roche and Takeda; research grants from Abbvie and Gilead, S.M.: advisor/lecturer for Abbvie, Gilead, Ipsen, Merck Sharp & Dohme, Roche, Integris and Genesis; research grants from Abbvie and Gilead. For the remaining authors, there are no conflicts of interest.
